Executive Summary: The global liquid biopsy market was valued at USD 2.69 billion in 2024 and is expected to reach USD 9.34 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 16.80%, primarily driven by the increasing cancer incidence This growth is driven by factors such as growth invasive testing, personalized medicine, and adva... https://www.databridgemarketresearch.com/reports/global-liquid-biopsy-market